MENU

Gilead Sciences Aktie
(WKN: 885823) (NASDAQ:GILD)

Gilead Sciences created and sells the world’s top-selling HIV medications, Truvada and Atripla, and commands about 75% of the U.S. treatment market and more than 50% worldwide.

{{ formattedPrice }} {{ change }} (-2,13 %)

Quotes delayed. Last trade: 21-02-2019, 10:00:01pm CET

GILD vs. S&P 500
Eröffnung {{ openPrice }} Schlusskurs {{ closePrice }}
Tages-Hoch {{ high }} Tages-Tief {{ low }}
Geld {{ bid }} Brief {{ ask }}
Volumen 5606896    

Related Articles